GEN Exclusives

More »

GEN News Highlights

Back to Item »

Immunexpress, Debiopharm, and Biocartis to Advance SeptiCyte Triage for Managing Sepsis

Debiopharm will make a A$2 million equity investment in Immunexpress.

Forward this item to a colleague:


(Separate multiple addresses by commas)


(Separate multiple addresses by commas)


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Climate Change

How would you describe the researchers response to the 2°C global temperature target?

More »